InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Brown Martin S JR. Director active across 1 company, notably Cumberland Pharmaceuticals INC. In total, 5 disclosures have been logged. Activity tracked since 24 March 2023. The latest transaction was disclosed on 18 March 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Brown Martin S JR is a Director of Cumberland Pharmaceuticals INC (XNAS). He has 5 filings in total, and the 5 sampled filings, from 2023-03-27 to 2026-03-20, show transactions of Attribution nature, with amounts of EUR 4751.281471317258, EUR 4367.613774311807, EUR 3955.572042023729, EUR 1818.172169867109, and EUR 1582.228816809492.